Reports for NOVARTIS PHARMACEUTICALS CANADA INC

Company Name

NOVARTIS PHARMACEUTICALS CANADA INC

Totals

Shortage reports

177

Actual shortage: 5 (3%)
Anticipated shortage: 0 (0%)
Avoided shortage: 5 (3%)
Resolved: 167 (94%)

Discontinuation Reports

54

To be discontinued: 1 (2%)
Discontinued: 53 (98%)
Reversed: 0 (0%)

Late reports

34 (15%)

Overdue reports

1 (17%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEGRETOL SUSPENSION 100MG SUSPENSION Actual shortage 2025-11-04 2025-11-05 271046
MAXIDEX 0.1% OINTMENT Actual shortage 2025-09-24 2025-09-29 267743
SANDOSTATIN LAR 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE Resolved 2025-07-14 2025-11-04 262673
ALOMIDE 0.1% SOLUTION Resolved 2025-07-14 2025-08-06 262619
PATADAY 0.2% SOLUTION Resolved 2025-07-02 2025-10-11 261501
ZOMETA CONCENTRATE 4MG SOLUTION Actual shortage 2025-06-02 2025-06-02 259079
TABRECTA 150MG TABLET Resolved 2025-06-02 2025-07-15 259074
MAXIDEX 0.1% OINTMENT Resolved 2025-04-28 2025-08-19 255940
TOBRADEX 0.1% 0.3% OINTMENT Resolved 2025-04-28 2025-08-19 255935
MAXITROL 6000UNIT 3.5MG 0.1% OINTMENT Resolved 2025-04-28 2025-08-19 255932
SANDOSTATIN LAR 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE Resolved 2025-04-03 2025-08-06 254019
SANDOSTATIN LAR 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE Resolved 2025-04-03 2025-08-06 254013
DUREZOL 0.05% EMULSION Resolved 2025-02-14 2025-04-18 250425
ALOMIDE 0.1% SOLUTION Resolved 2025-01-17 2025-03-18 247997
TEGRETOL CR 400MG TABLET (EXTENDED-RELEASE) Resolved 2024-12-09 2025-02-05 245118
VOLTAREN OPHTHA 0.1% SOLUTION Resolved 2024-11-28 2025-02-19 244108
DESFERAL 500MG 500MG POWDER FOR SOLUTION Resolved 2024-10-01 2025-01-07 239097
TEGRETOL CR 400MG TABLET (EXTENDED-RELEASE) Resolved 2024-10-01 2024-11-02 239094
TEGRETOL SUSPENSION 100MG SUSPENSION Resolved 2024-08-27 2024-11-26 235981
TEGRETOL CR 200MG TABLET (EXTENDED-RELEASE) Resolved 2024-08-27 2024-12-09 235978

Showing 1 to 20 of 177

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
BETOPTIC S 0.25% SUSPENSION Discontinued 2025-03-11 2025-06-02 252361
LAMISIL 250MG TABLET To be discontinued 2024-11-28 2024-11-28 244096
FLAREX 0.1% SUSPENSION Discontinued 2024-08-27 2024-11-28 235987
SANDOSTATIN 100MCG SOLUTION Discontinued 2024-03-22 2024-03-22 223070
TASIGNA 50MG CAPSULE Discontinued 2023-10-19 2023-11-06 207564
LIORESAL INTRATHECAL 0.5MG/ML 0.5MG SOLUTION Discontinued 2023-08-17 2023-09-19 202298
LIORESAL INTRATHECAL 0.05MG/ML 0.05MG SOLUTION Discontinued 2023-08-10 2023-09-19 201576
LIORESAL INTRATHECAL 2MG/ML 2MG SOLUTION Discontinued 2023-08-10 2023-09-19 201573
ZOFRAN 8MG TABLET Discontinued 2023-04-13 2023-05-08 189538
ZOFRAN 4MG TABLET Discontinued 2023-04-13 2023-05-08 189513
FORADIL DRY POWDER CAPSULES FOR INHALATION 12MCG CAPSULE Discontinued 2022-10-18 2023-01-25 172087
BETOPTIC S 0.25% SUSPENSION Discontinued 2022-09-28 2023-01-19 170389
ZOFRAN 4MG SOLUTION Discontinued 2022-06-29 2022-10-18 163685
ONBREZ BREEZHALER 75MCG CAPSULE Discontinued 2022-06-29 2022-07-14 163682
ONBREZ BREEZHALER 75MCG CAPSULE Discontinued 2022-06-29 2022-07-14 163678
ISOPTO CARPINE 4% LIQUID Discontinued 2022-05-11 2022-07-14 160361
RITALIN 10MG 10MG TABLET Discontinued 2022-02-08 2022-05-11 154449
RITALIN-SR TAB 20MG 20MG TABLET (EXTENDED-RELEASE) Discontinued 2022-02-08 2022-04-05 154439
SANDOSTATIN 200MCG SOLUTION Discontinued 2022-02-08 2022-03-07 154429
EXTAVIA 0.3MG POWDER FOR SOLUTION Discontinued 2022-01-12 2022-02-11 152532

Showing 1 to 20 of 54